Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001437749-26-002576 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 30, 2026 |
| Document Date | Jan 30, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
166,500
Total Value
$0.00
P&L
+inf% (+$2,032,965.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Jan 30, 2026 | Grant/Award | 160,000 | $0.00 | $0.00 | 160,000 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Jan 30, 2026 | Grant/Award | 6,500 | $0.00 | $0.00 | 6,500 | Indirect | By Spouse | View Details |